SageView Advisory Group LLC Sells 1,299 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

SageView Advisory Group LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 31.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,843 shares of the medical equipment provider’s stock after selling 1,299 shares during the period. SageView Advisory Group LLC’s holdings in Intuitive Surgical were worth $1,396,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Ridgewood Investments LLC purchased a new stake in Intuitive Surgical in the 2nd quarter valued at $26,000. Godsey & Gibb Inc. increased its holdings in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares during the last quarter. LGT Financial Advisors LLC boosted its holdings in Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after buying an additional 54 shares during the period. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical in the third quarter valued at approximately $33,000. Finally, Mark Sheptoff Financial Planning LLC bought a new position in shares of Intuitive Surgical in the second quarter worth $37,000. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, Director Amy L. Ladd sold 450 shares of the company’s stock in a transaction that occurred on Friday, September 13th. The shares were sold at an average price of $490.28, for a total transaction of $220,626.00. Following the transaction, the director now owns 821 shares of the company’s stock, valued at approximately $402,519.88. This represents a 35.41 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction dated Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 51,023 shares of company stock valued at $26,384,247. 0.90% of the stock is currently owned by insiders.

Intuitive Surgical Trading Down 0.4 %

Intuitive Surgical stock opened at $547.65 on Friday. Intuitive Surgical, Inc. has a twelve month low of $307.72 and a twelve month high of $552.08. The firm has a market capitalization of $195.06 billion, a P/E ratio of 88.05, a P/E/G ratio of 5.33 and a beta of 1.38. The stock’s fifty day simple moving average is $514.78 and its 200-day simple moving average is $472.60.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, beating analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to analyst estimates of $2.01 billion. Sell-side analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Stifel Nicolaus boosted their price target on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday. Truist Financial lifted their price target on Intuitive Surgical from $520.00 to $570.00 and gave the stock a “buy” rating in a research note on Monday, October 14th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and raised their target price for the stock from $522.00 to $650.00 in a report on Monday. Wells Fargo & Company lifted their price objective on Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research report on Friday, October 18th. Finally, Leerink Partners raised their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $541.33.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.